Shares of digital technology company BullFrog AI Holdings, Inc. (BFRG) are rising more than 30% after the company announced worldwide license agreement with Johns Hopkins University Applied Physics Laboratory for use of patented technology powering the Company’s bfLEAP platform.
BullFrog said its bfLEAP platform analyzes drug development data to potentially make life-saving therapies and treatments available to patients more quickly.
“The ability to make predictions with incomplete multimodal data and insufficient scalability of digital analytics are two critical issues for researchers and clinicians today,” said Vin Singh, Founder and CEO of BullFrog AI. “With the help of John Hopkins APL’s patented technology, our bfLEAP platform is able to overcome these challenges, enabling precise identification of meaningful data for more agile drug development.”
BFRG, currently at $6.29, has been trading in the range of $2.47-$9.50 in the last 1 year.
Source: Read Full Article
-
NYDIG Predicts Spot Bitcoin ETFs Could Unlock $30 Billion In Fresh Demand
-
Cryptos Muted Ahead Of Inflation Update
-
Cryptos Rise As Powell Sounds Less Hawkish Than Feared
-
Ciena Slides On Lower Profit, Revenue Below Estimates In Q3
-
Bitcoin (BTC) Market Cap Overtakes Berkshire Hathaway and Tesla – Now Among Top 10 Assets Globally